Patents by Inventor Esben Peter Friis

Esben Peter Friis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Alpha-amylase variants
    Patent number: 10167458
    Abstract: The present invention relates to variants of a parent alpha-amylase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: July 25, 2016
    Date of Patent: January 1, 2019
    Assignee: NOVOZYMES A/S
    Inventors: Svend Kaasgaard, Jens Oebro, Signe Eskildsen Larsen, Allan Svendsen, Annette Helle Johansen, Michael Skjoet, Carsten Andersen, Lars Beier, Esben Peter Friis, Miguel Duarte Guilherme Pereira Toscano, Mads Bjoernvad, Frank Winther Rasmussen, Liv Spaanger Christiansen
  • PROTEASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20180355338
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: December 18, 2015
    Publication date: December 13, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Frank W. Rasmussen, Miguel Duarte Guilherme Pereira Toscano, Lars L.H. Christensen, Esben Peter Friis
  • Protease variants and polynucleotides encoding same
    Patent number: 10150957
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: December 11, 2018
    Assignee: Novozymes A/S
    Inventors: Frank Winther Rasmussen, Rolf Thomas Lenhard, Miguel Duarte Guilherme Perreira Toscano, Esben Peter Friis, Signe Eskildsen Larsen, Jurgen Carsten Franz Knotzel, Mikael Bauer
  • Glucoamylase variants and polynucleotides encoding same
    Patent number: 10113158
    Abstract: The present invention relates to glucoamylase variants having improved thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: October 30, 2018
    Assignee: NOVOZYMES A/S
    Inventors: Esben Peter Friis, Leonardo De Maria, Jesper Vind, Thomas A. Poulsen, Allan Svendsen, Steffen Danielsen, Rolf T. Lenhard, Henrik Friis-Madsen, Lars K. Skov
  • ALPHA-AMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20180273925
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: June 7, 2018
    Publication date: September 27, 2018
    Applicant: Novozymes A/S
    Inventors: Carsten Andersen, Signe Eskildsen Larsen, Esben Peter Friis, Peter Kamp Hansen, Henrik Friis Madsen, Anders Viksoe Nielsen, Pernille Ollendorf Micheelsen
  • SUBTILASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20180265855
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 20, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Werner Besenmatter, Astrid Benie, Esben Peter Friis, Pernille Ollendorf Micheelsen
  • ALBUMIN VARIANTS
    Publication number: 20180265570
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 20, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • ALBUMIN VARIANTS
    Publication number: 20180222963
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: January 12, 2018
    Publication date: August 9, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • Variants of a family 44 xyloglucanase
    Patent number: 10035998
    Abstract: The present invention relates to variants of a parent xyloglucanase. The present invention also relates to polynucleotides encoding the variant xyloglucanases and to nucleic acid constructs, vectors, and host cells comprising the polynucleotide.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: July 31, 2018
    Assignee: Novozymes A/S
    Inventors: Werner Besenmatter, Esben Peter Friis, Keith Gibson, Frank Winther Rasmussen, Michael Skjoet
  • Alpha-amylase variants and polynucleotides encoding same
    Patent number: 10017752
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: July 10, 2018
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Signe Eskildsen Larsen, Esben Peter Friis, Peter Kamp Hansen, Henrik Friis-Madsen, Anders Viksoee Nielsen, Pernille Ollendorf Micheelsen
  • Protease Variants and Polynucleotides Encoding Same
    Publication number: 20180171319
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: February 8, 2018
    Publication date: June 21, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Frank Winther Rasmussen, Rolf Thomas Lenhard, Miguel Duarte Guilherme Perreira Toscano, Esben Peter Friis, Signe Eskildsen Larsen, Jurgen Carsten Franz Knotzel, Michael Bauer
  • ALBUMIN VARIANTS
    Publication number: 20180162925
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: January 12, 2018
    Publication date: June 14, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • ALBUMIN VARIANTS
    Publication number: 20180105577
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: September 19, 2017
    Publication date: April 19, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • ALBUMIN VARIANTS
    Publication number: 20180105578
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: September 19, 2017
    Publication date: April 19, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • ALBUMIN VARIANTS
    Publication number: 20180105576
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: September 19, 2017
    Publication date: April 19, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • GLUCOAMYLASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
    Publication number: 20180094252
    Abstract: The present invention relates to variants of a parent glucoamylase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the glucoamylase variants.
    Type: Application
    Filed: December 14, 2017
    Publication date: April 5, 2018
    Applicant: NOVOZYMES A/S
    Inventors: Jesper Vind, Esben Peter Friis, Thomas Agsersten Poulsen, Michael Skjøt, Peter Kamp Hansen, Frank Winther Rasmussen, Steen Krogsgaard, Joyce Craig, Guillermo Coward-Kelly, Keiichi Ayabe
  • Protease variants and polynucleotides encoding same
    Patent number: 9926550
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: March 27, 2018
    Assignee: Novozymes A/S
    Inventors: Frank Winther Rasmussen, Rolf Thomas Lenhard, Miguel Duarte Guilherme Perreira Toscano, Esben Peter Friis, Signe Eskildsen Larsen, Jurgen Carsten Franz Knotzel, Michael Bauer
  • ALBUMIN VARIANTS
    Publication number: 20180072792
    Abstract: The present invention relates to variants of a parent albumin having altered plasma half-life compared with the parent albumin. The present invention also relates to fusion polypeptides and conjugates comprising said variant albumin.
    Type: Application
    Filed: September 19, 2017
    Publication date: March 15, 2018
    Inventors: Darrell Sleep, Andrew Plumridge, Jason Cameron, Inger Sandlie, Jan Terje Andersen, Esben Peter Friis
  • Glucoamylase variants and polynucleotides encoding same and uses thereof
    Patent number: 9879241
    Abstract: The present invention relates to variants of a parent glucoamylase. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the glucoamylase variants.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: January 30, 2018
    Assignee: NOVOZYMES A/S
    Inventors: Jesper Vind, Esben Peter Friis, Thomas Agsersten Poulsen, Michael Skjøt, Peter Kamp Hansen, Frank Winther Rasmussen, Steen Krogsgaard, Joyce Craig, Guillermo Coward-Kelly, Keiichi Ayabe
  • PROTEASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME
    Publication number: 20170349890
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: December 18, 2015
    Publication date: December 7, 2017
    Applicant: NOVOZYMES A/S
    Inventors: Frank W. Rasmussen, Miguel Duarte Guilherme Pereira Toscano, Lars L.H. Christensen, Esben Peter Friis